Asarfi Hospital September-quarter profit rises 43% to Rs 6.14 crore

Asarfi Hospital Limited reported standalone profit after tax of Rs 6.14 crore for the quarter ended 30 September 2026, up 43% year on year, as revenue from operations rose 18% to Rs 52.87 crore. The increase in profit exceeded revenue growth despite higher employee benefit, finance and other expenses during the quarter.

How did Asarfi Hospital perform in the September 2026 quarter?

Asarfi Hospital recorded total income of Rs 53.58 crore in the quarter ended 30 September 2026, up from Rs 45.64 crore in the quarter ended 30 September 2025. Revenue from operations supplied Rs 52.87 crore of the latest-quarter total, compared with Rs 44.85 crore a year earlier, while other income declined to Rs 70.90 lakh from Rs 79.75 lakh.

Profit before tax rose 44% year on year to Rs 8.29 crore from Rs 5.76 crore. After current tax of Rs 2.27 crore and a deferred-tax credit of Rs 12.28 lakh, profit after tax reached Rs 6.14 crore, compared with Rs 4.30 crore in the year-earlier quarter. There were no exceptional or extraordinary items in either period.

Asarfi Hospital’s quarterly profit also improved sequentially from Rs 4.27 crore in the quarter ended 30 June 2026. Revenue from operations rose from Rs 47.34 crore in June to Rs 52.87 crore in September, a 12% quarter-on-quarter increase. Profit before tax increased from Rs 5.71 crore, while total income rose from Rs 47.94 crore.

What drove the gap between revenue and profit growth?

Asarfi Hospital’s profit grew faster than revenue because total expenses increased 14% year on year to Rs 45.29 crore, slower than the 17% increase in total income to Rs 53.58 crore. Based on the reported figures, profit before tax represented about 15.5% of total income in the September 2026 quarter, compared with about 12.6% a year earlier.

Employee benefit expenses rose 25% to Rs 7.64 crore from Rs 6.10 crore. Other expenses, the largest disclosed expense category, rose 16% to Rs 22.40 crore from Rs 19.25 crore. Finance costs increased 19% to Rs 1.27 crore, while depreciation and amortisation rose 6% to Rs 3.05 crore.

Material consumption moved differently from these cost lines. Cost of material consumed was Rs 7.36 crore, marginally below Rs 7.40 crore a year earlier, and purchases of stock in trade were Rs 3.29 crore versus Rs 3.31 crore. The company also reported an inventory-related expense of Rs 28.32 lakh, compared with a Rs 11.83 lakh credit in the prior-year quarter.

Asarfi Hospital’s current-tax expense rose to Rs 2.27 crore from Rs 1.38 crore, consistent with the higher pre-tax profit. The deferred-tax line changed from an expense of Rs 7.09 lakh in the September 2025 quarter to a credit of Rs 12.28 lakh in the latest quarter. Basic and diluted earnings per share were both Rs 3.12, up from Rs 2.19.

What do Asarfi Hospital’s half-year results show?

Asarfi Hospital reported revenue from operations of Rs 100.21 crore for the half year ended 30 September 2026, up 24% from Rs 80.51 crore in the corresponding half year ended 30 September 2025. Total income rose to Rs 101.51 crore from Rs 82.72 crore, even though other income fell to Rs 1.30 crore from Rs 2.21 crore.

Half-year profit after tax increased 39% to Rs 10.41 crore from Rs 7.50 crore. Profit before tax rose 40% to Rs 13.99 crore from Rs 10.03 crore, while total expenses were Rs 87.52 crore compared with Rs 72.69 crore. The 20% rise in expenses was below the 23% increase in total income.

Employee benefit expenses in the first half rose to Rs 15.50 crore from Rs 11.88 crore, while other expenses rose to Rs 41.62 crore from Rs 33.52 crore. Material consumption increased to Rs 14.84 crore from Rs 13.31 crore, and finance costs were Rs 2.44 crore compared with Rs 2.28 crore. Basic and diluted half-year earnings per share rose to Rs 5.29 from Rs 3.81.

Asarfi Hospital identifies Hospital as its only reportable segment under Accounting Standard 17, or AS 17. The filing therefore does not provide separate revenue, profit, asset or margin figures for individual hospital services, facilities, geographies or patient categories. It also says its shares are listed on an SME exchange and that it is exempt from mandatory adoption of Indian Accounting Standards under the cited Ministry of Corporate Affairs notification.

How did cash flow and the balance sheet change by September?

Asarfi Hospital generated net cash from operating activities of Rs 7.35 crore in the half year ended 30 September 2026, lower than Rs 9.28 crore in the comparable 2025 half year, despite profit after tax rising to Rs 10.41 crore. The main disclosed working-capital movement was a Rs 21.12 crore increase in trade receivables, compared with a Rs 7.05 crore increase in the prior-year half.

Trade receivables on the balance sheet stood at Rs 75.18 crore at 30 September 2026, up from Rs 54.07 crore at 31 March 2026. Inventories fell to Rs 2.79 crore from Rs 3.22 crore. Trade payables due to micro and small enterprises rose to Rs 19.94 crore from Rs 14.63 crore, while payables due to others increased to Rs 2.65 crore from Rs 1.93 crore.

Investing activities used Rs 3.90 crore in the first half, compared with Rs 5.34 crore used a year earlier. Purchases of property, plant and equipment and capital work-in-progress were Rs 6.17 crore, versus Rs 5.06 crore. Capital work-in-progress rose to Rs 6.24 crore at September-end from Rs 1.76 crore at 31 March 2026, while property, plant and equipment declined to Rs 103.92 crore from Rs 108.14 crore.

Financing activities used Rs 4.36 crore, compared with Rs 2.92 crore in the prior-year half, including Rs 3.86 crore of long-term borrowing repayments and Rs 2.44 crore of interest paid. Long-term borrowings were Rs 32.66 crore at 30 September 2026, down from Rs 35.01 crore at 31 March, whereas short-term borrowings rose to Rs 22.98 crore from Rs 22.55 crore. Cash and cash equivalents in the cash-flow statement ended at Rs 5.19 crore, compared with Rs 6.10 crore at the start of the half year.

Conclusion

Asarfi Hospital’s September-quarter results show that profit after tax increased faster than operating revenue, with Rs 6.14 crore of profit on Rs 52.87 crore of revenue. The same pattern extended into the first half, when total income rose 23% while total expenses increased 20%, and Hospital remained the sole reportable segment.

The next reported results will show whether the Rs 6.24 crore capital work-in-progress progresses, whether trade receivables move from the Rs 75.18 crore balance at 30 September 2026, and whether operating cash generation improves from Rs 7.35 crore in the first half.